Trial Profile
A Phase II Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Single Bolus i.v. Tenecteplase Versus Placebo in Normotensive Patients With Pulmonary Embolism and Right Ventricular Dysfunction
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2009
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Pulmonary embolism
- Focus Therapeutic Use
- 20 Nov 2005 New trial record.